Craig R. Malloy

Craig R. Malloy

Auto-generated profile, based on publicly available information

Craig R. Malloy

University of Texas Southwestern Medical Center

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Cell
Verified
Journal Article
Closed access
BFBrandon Faubert
Brandon Faubert
KLKevin Y. Li
Kevin Y. Li
LCLing Cai
Ling Cai
CHChristopher T. Hensley
Christopher T. Hensley
JKJiyeon Kim
Jiyeon Kim
RDRalph J. DeBerardinis
Ralph J. DeBerardinis

1 February 2016 in Cell
Verified
Journal Article
Closed access
CHChristopher T. Hensley
Christopher T. Hensley
BFBrandon Faubert
Brandon Faubert
QYQing Yuan
Qing Yuan
NLNaama Lev-Cohain
Naama Lev-Cohain
EJEunsook Jin
Eunsook Jin
RDRalph J. DeBerardinis
Ralph J. DeBerardinis

26 January 2012 in Nature Medicine
Verified
Journal Article
Open access
PDF file
CCChangho Choi
Changho Choi
SGSandeep K Ganji
Sandeep K Ganji
RDRalph J DeBerardinis
Ralph J DeBerardinis
KHKimmo J Hatanpaa
Kimmo J Hatanpaa
DRDinesh Rakheja
Dinesh Rakheja
EMElizabeth A Maher
Elizabeth A Maher
Mutations in isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in the majority of people with grade 2 and 3 gliomas is associated with elevated levels of 2-hydroxyglutarate (2HG) within the tumor. As harboring IDH1 or IDH2 mutations confers a considerable survival benefit in these individuals, there has been considerable interest in studying this metabolite as a potential biomarker. Here, Changho Choi et al. report the successful noninvasive detection of 2HG in 30 subjects with gliomas using a proton magnetic resonance spectroscopy approach. Mutations in isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) have been shown to be present in most World Health Organization grade 2 and grade 3 gliomas in adults. These mutations are associated with the accumulation of 2-hydroxyglutarate (2HG) in the tumor. Here we report the noninvasive detection of 2HG by proton magnetic resonance spectroscopy (MRS). We developed and optimized the pulse sequence with numerical and phantom analyses for 2HG detection, and we estimated the concentrations of 2HG using spectral fitting in the tumors of 30 subjects. Detection of 2HG correlated with mutations in IDH1 or IDH2 and with increased levels of D-2HG by mass spectrometry of the resected tumors. Noninvasive detection of 2HG may prove to be a valuable diagnostic and prognostic biomarker.

1 August 2015 in Current Opinion in Biotechnology
Verified
Journal Article
Open access
JBJoerg Buescher
Joerg Buescher
MAMaciek R Antoniewicz
Maciek R Antoniewicz
LBLaszlo G Boros
Laszlo G Boros
SBShawn C Burgess
Shawn C Burgess
HBHenri Brunengraber
Henri Brunengraber
SFSarah-Maria Fendt
Sarah-Maria Fendt
Measuring intracellular metabolism has increasingly led to important insights in biomedical research. 13C tracer analysis, although less information-rich than quantitative 13C flux analysis that requires computational data integration, has been established as a time-efficient method to unravel relative pathway activities, qualitative changes in pathway contributions, and nutrient contributions. Here, we review selected key issues in interpreting 13C metabolite labeling patterns, with the goal of drawing accurate conclusions from steady state and dynamic stable isotopic tracer experiments.

1 February 2011 in Neoplasia
Verified
Journal Article
Open access
JKJohn Kurhanewicz
John Kurhanewicz
DVDaniel B. Vigneron
Daniel B. Vigneron
KBKevin Brindle
Kevin Brindle
ECEduard Y Chekmenev
Eduard Y Chekmenev
ACArnaud Comment
Arnaud Comment
CMCraig R. Malloy
Craig R. Malloy
A major challenge in cancer biology is to monitor and understand cancer metabolism in vivo with the goal of improved diagnosis and perhaps therapy. Because of the complexity of biochemical pathways, tracer methods are required for detecting specific enzyme-catalyzed reactions. Stable isotopes such as (13)C or (15)N with detection by nuclear magnetic resonance provide the necessary information about tissue biochemistry, but the crucial metabolites are present in low concentration and therefore are beyond the detection threshold of traditional magnetic resonance methods. A solution is to improve sensitivity by a factor of 10,000 or more by temporarily redistributing the populations of nuclear spins in a magnetic field, a process termed hyperpolarization. Although this effect is short-lived, hyperpolarized molecules can be generated in an aqueous solution and infused in vivo where metabolism generates products that can be imaged. This discovery lifts the primary constraint on magnetic resonance imaging for monitoring metabolism-poor sensitivity-while preserving the advantage of biochemical information. The purpose of this report was to briefly summarize the known abnormalities in cancer metabolism, the value and limitations of current imaging methods for metabolism, and the principles of hyperpolarization. Recent preclinical applications are described. Hyperpolarization technology is still in its infancy, and current polarizer equipment and methods are suboptimal. Nevertheless, there are no fundamental barriers to rapid translation of this exciting technology to clinical research and perhaps clinical care.

1 June 2012 in Cell Metabolism
Verified
Journal Article
Closed access
IMIsaac Marin-Valencia
Isaac Marin-Valencia
CYChendong Yang
Chendong Yang
TMTomoyuki Mashimo
Tomoyuki Mashimo
SCSteve Cho
Steve Cho
HBHyeonman Baek
Hyeonman Baek
RBRobert M. Bachoo
Robert M. Bachoo